Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  BRAF(V600E) inhibitor CEP-32496
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: RXDX-105-01, NCI-2013-01795, C32496/1105, NCT01877811
Start Over